ORIGINAL RESEARCH article
Front. Microbiol.
Sec. Infectious Agents and Disease
Volume 16 - 2025 | doi: 10.3389/fmicb.2025.1655490
This article is part of the Research TopicRapid and Efficient Analytical Technologies for Pathogen DetectionView all 12 articles
In silico and in vitro analyses for the improved diagnosis of bacterial meningitis
Provisionally accepted- 1Swiss Centre for Scientific Research (Côte d'Ivoire), Abidjan, Côte d'Ivoire
- 2University of Oxford, Oxford, United Kingdom
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Context: Diagnosing meningitis remains challenging with etiological agents frequently unidentified. Using both in silico and in vitro approaches, this study evaluated published and novel genetic targets for the detection of common bacterial species known to cause meningitis: Neisseria meningitidis, Streptococcus agalactiae, Streptococcus pneumoniae and Haemophilus influenzae. Methods: A total of 29 genetic targets were investigated for the detection of N. meningitidis, S. agalactiae, S. pneumoniae and H. influenzae, using the Gene Presence tool and whole genome sequence data (WGS) found in the genomics platform, PubMLST. These targets were further tested in silico by screening WGS using the PCR tool hosted on PubMLST allowing the sensitivity, specificity, Negative Predicted Values (NPV) and Positive Predictive Values (PPV) to be determined. Ten targets were then further evaluated in vitro by real-time PCR against a panel of 44 bacterial isolates representative of the genera evaluated. Results: The best performing in silico genetic determinants targeted: N. meningitidis, sodC (NEIS1339) (sensitivity 99.7%, specificity, 99.4%, PPV, 99.6% and NPV, 99.6%); S. pneumoniae, SP2020 (99.5%, 99.9%, 99.9% and 81.5%) and H. influenzae, dmsA (HAEM1183) (98%, 100%, 99.6% and 77.4%). All three of these targets also had the best in vitro sensitivity (100%), specificity (91.7% sodC (NEIS1339), 100% SP2020 and 97.3% dmsA (HAEM1183), PPV (72.7% sodC (NEIS1339), 100% SP2020 and 87.5% dmsA (HAEM1183),) and NPV (100% for all targets). The gene sip (SAG0032) encoding the surface immunogenic protein (sip) exhibited the best sensitivity (99.6%) and NPV (96.9%) for S. agalactiae compared to 99.3% and 94.8% for cfb (SAG2043), respectively in silico. However, in vitro, cfb showed the best sensitivity (100% vs 85.7%) and NPV (100% vs 97.4%) when compared to sip. Conclusion: SodC, cfb, SP2020, and dmsA have the potential to enhance the accuracy of molecular diagnostics for the four most common bacterial species causing meningitis. Moreover, a combined in silico and in vitro approach that leverages WGS deposited in databases such as PubMLST, offers an efficient and cost-effective means for the preliminary evaluation of diagnostic targets.
Keywords: Meningitis, Molecular diagnostic, in silico analysis, Sensitivity, specificity
Received: 30 Jun 2025; Accepted: 08 Sep 2025.
Copyright: © 2025 AMOIKON, Diallo, Tuo, Nasir, Feteh, Mzumara, Aderoba, Jacques, Mandal, Jolley, BRAY, Harrison and Maiden. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Kanny Diallo, Swiss Centre for Scientific Research (Côte d'Ivoire), Abidjan, Côte d'Ivoire
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.